Budesonide Oral Suspension (Anhydrous)
Budesonide is a compounded formulation containing Budesonide, prepared by Mixlab for veterinary use. Available by prescription.
How to Give Anhydrous Oral Suspension
Oral Suspension (Anhydrous) is a liquid medication that does not contain water in its base. This might be an oil-based or other special base to help stabilize the medicine. It will look like a regular liquid medication, but often needs a good shake because the drug can settle. Here's how to give it:
- Shake well each time to mix the medication (5-10 seconds).
- Measure the dose using the syringe/dropper provided or one recommended by your vet. Insert the top of the oral syringe into the bottle adapter. Turn the bottle upside down and pull the plunger until the medicine reaches the volume required
- Hold your pet steady: a towel or helper can assist with squirmy pets.
- Administer the dose slowly into the side of the mouth. Allow small pauses if needed for swallowing.
- Raise the head slightly to help the medication go down and clean any spills with a little water or tissue.
- Praise your pet and offer a treat or water (unless advised against feeding right after).
- Clean the syringe with water immediately after use. Store the bottle as directed, out of sunlight.
- Consistency is key: Shake each time, measure accurately, and contact your vet if any issues arise.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Veterinarians most commonly consider budesonide for the management of gastrointestinal health challenges, such as inflammatory bowel disease (IBD). It is frequently a point of discussion for patients that require long-term anti-inflammatory support but may be sensitive to the side effects of medications like prednisolone. By targeting the inflammatory environment within the digestive tract, your veterinarian can manage localized tissue swelling while addressing the amount of medication that reaches the rest of the body.
At a pharmacological level, budesonide acts by binding to glucocorticoid receptors in the cytoplasm of cells. This action help address the transcription of several genes responsible for the synthesis of pro-inflammatory cytokines and enzymes. Budesonide is characterized by a high first-pass metabolism in the liver; once the medication is absorbed from the intestinal lumen, it is rapidly converted into metabolites with significantly lower biological activity. This unique pharmacokinetic profile allows for high localized activity in the intestinal mucosa with relatively low systemic bioavailability. Your veterinarian will determine the clinical appropriateness of budesonide based on your pet’s health history and the results of diagnostic imaging or biopsies.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
Commonly observed effects following the administration of budesonide include mild gastrointestinal shifts or changes in appetite. While budesonide is selected in the context of addressing systemic influence, some pets may still exhibit classic steroid-related behaviors such as increased thirst (polydipsia) or increased urination (polyuria), though these are often less pronounced than with other prescriptions. Owners should watch for signs of localized hair loss, lethargy or muscle weakness and contact their veterinarian promptly if these behavioral shifts occur.
This medication is typically used with extra caution or avoided in patients with known severe hepatic impairment, as addressed liver function can increase the amount of active medication in the systemic circulation. It is also carefully evaluated in pets with active infections, as glucocorticoids can influence the body's natural immune response. Before starting a protocol, ensure your veterinarian has a complete history of all other medications your pet is receiving, especially antifungal medications or certain antibiotics that can interfere with the metabolism of budesonide. Your veterinarian is the right person to provide guidance on the necessary duration of use and the proper monitoring schedule to ensure the management approach remains suitable for your pet's individual needs.
Yes. Budesonide is a prescription medication and can only be dispensed by a licensed pharmacy upon receipt of a valid authorization from a licensed veterinarian. Mixlab verifies all authorizations before any medication is prepared or shipped to your home.
Yes. Budesonide is frequently compounded by Mixlab into customized strengths and pet-friendly formats, such as flavored oral liquids or small capsules. Because commercial human formulations are often not sized appropriately for smaller animals, compounding allows your veterinarian to prescribe a dose tailored specifically to your pet's weight.
Veterinarians often discuss budesonide for pets with inflammatory bowel disease because it works primarily in the gut and is broken down quickly by the liver before it can affect the rest of the body. This management approach is often preferred for pets that have had difficulty tolerating the systemic side effects of other steroid medications.
You should monitor your pet for any significant changes in drinking or urinating habits, as well as shifts in energy levels or skin condition. While budesonide acts to have fewer side effects than traditional steroids, you should still report any unusual physical or behavioral changes to your veterinarian immediately.
